Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01007955 · ClinicalTrials.gov registry record

Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery

A clinical trial of Insulin Resistance and Non-alcoholic Fatty Liver Disease, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
61
Enrollment target
1
Study location

NCT01007955 is a study of Insulin Resistance and Non-alcoholic Fatty Liver Disease that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 61 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01007955, a study of Insulin Resistance and Non-alcoholic Fatty Liver Disease, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
61 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to further study the effect weight loss after gastric bypass surgery has on the heart and blood pressure and on how the body uses or metabolizes the sugars, fats and proteins we eat. Additionally, the researchers want to study fat tissue for gene patterns which may be responsible for where we carry fat on our bodies, as well as look carefully at a possible link between adipose tissue and insulin resistance. The researchers also want to evaluate the liver for the presence of fatty liver, which is common in people with obesity and is associated with insulin resistance, as well as study the liver for gene patterns which may be associated with non-alcoholic liver disease. Evaluating cardiovascular function and endocrine function before and after gastric bypass surgery, as well as studying adipose and liver tissue may help us understand the link between obesity, insulin resistance, fatty liver disease, high blood pressure and health problems such as diabetes and heart disease. Consequently, this may help in the future by identifying those who will benefit most from gastric bypass surgery.

Conditions Studied

Insulin Resistance Non-alcoholic Fatty Liver Disease Morbid Obesity

Study Locations (1)

Massachusetts

  • UMass Memorial Medical Center - Worcester

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2006-11
Est. Completion 2012-05

Sponsor

University of Massachusetts, Worcester

240 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01007955

The ClinicalTrials.gov registry entry for NCT01007955 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (75% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 0 interventions.

NCT01007955 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01007955 about?

NCT01007955 is a clinical study titled "Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery". The purpose of this research is to further study the effect weight loss after gastric bypass surgery has on the heart and blood pressure and on how the body uses or metabolizes the sugars, fats and proteins we eat. Additionally, the researchers want to study fat tissue for gene patterns which may be...

What is the current status of trial NCT01007955?

This trial is currently completed. The enrollment target is 61 participants. The study started on 2006-11. Estimated completion is 2012-05.

What conditions does trial NCT01007955 study?

This clinical trial studies the following conditions: Insulin Resistance, Non-alcoholic Fatty Liver Disease, Morbid Obesity.

Who is sponsoring clinical trial NCT01007955?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01007955 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insulin Resistance

All registered trials for this condition

Non-alcoholic Fatty Liver Disease

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.